Complicated Skin and Skin Structure Infections
5 clinical trials · Condition
◉ Watch Complicated Skin and Skin Structure Infections
| Record | Firm | Date |
|---|---|---|
| Telavancin Observational Use Registry (TOUR) (NCT02288234) | Cumberland Pharmaceuticals | 2014-11-01 |
| Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) (NCT01128530) | Furiex Pharmaceuticals, Inc | 2010-06-01 |
| Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment (NCT01072539) | Pfizer | 2010-05-01 |
| Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment (NCT01104662) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2010-04-19 |
| Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) (NCT00683332) | Pfizer | 2007-04-01 |
Track Complicated Skin and Skin Structure Infections automatically
Every clearance here is in the API, with alerts when new ones post.